http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#head http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#assertion http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#provenance http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#publicationInfo http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#assertion http://bio2rdf.org/drugbank:DB00915 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00915_DB01267 http://bio2rdf.org/drugbank:DB01267 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00915_DB01267 http://bio2rdf.org/drugbank_resource:DB00915_DB01267 http://purl.org/dc/terms/identifier drugbank_resource:DB00915_DB01267 http://bio2rdf.org/drugbank_resource:DB00915_DB01267 http://purl.org/dc/terms/title DDI between Amantadine and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, amantadine. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary. http://bio2rdf.org/drugbank_resource:DB00915_DB01267 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00915_DB01267 http://www.w3.org/2000/01/rdf-schema#label DDI between Amantadine and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, amantadine. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary. [drugbank_resource:DB00915_DB01267] http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#provenance http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#publicationInfo http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#signature.MC0CFCtWkMiL6I50 http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#signature.MC0CFCtWkMiL6I50 http://purl.org/nanopub/x/hasSignature MC0CFCtWkMiL6I501TJ93ui/7JsmOxUMAhUAlO2gtLwDCtGII97ZsvALYS5sOKc= http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#signature.MC0CFCtWkMiL6I50 http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ http://purl.org/dc/terms/created 2018-03-30T11:12:37.821+02:00 http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#signature.MC0CFCtWkMiL6I50 http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234